A BIO-RAD developed chromogenic medium has received FDA clearance for faster interpretation time in the screening of methicillin-resistant Staphylococcus aureus (MRSA).
28/01/2009
SPECTRUM Pharmaceuticals has announced the FDA has granted Fast Track Designation for the investigation of apaziquone (EOquin) for the treatment of non-muscle invasive bladder cancer.
24/07/2009
PARNELL has opened the doors on its FDA-approved manufacturing plant in Sydney.
07/08/2009
CRYOLIFE has announced it has received FDA http://www.fda.gov/ clearance for a pulmonary human heart valve.
19/02/2009
MERCK has announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets designed for investigational oral formulation of cladribine.
01/10/2009
MYLAN has announced that Matrix Laboratories has received the first and only tentative approval from the US Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief.
13/03/2009
PRIMA Biomed has secured $12m in funding to advance the commercialisation of the CVac ovarian cancer vaccine treatment product.
01/01/1980
VANDA Pharmaceuticals has compiled a report titled the “Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia" for Schizophrenia Research, the official journal of the Schizophrenia International Research Society.
13/03/2009
MERCK has announced it has obtained the U.S. distribution rights for CSL Limited's Afluria, one of the few flu vaccines approved for the U.S. market.
30/09/2009
NOVARTIS has been granted Marketing Authorisation by the European Commission for its Ixiaro Vaccine developed for the prevention of Japanese Encephalitis (JE).
06/04/2009
THE Blanchette Rockefeller Neurosciences Institute (BRNI) has received a green light from the FDA to enter Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
24/04/2009
RESEARCHERS in Sweden have reported that the full array of molecules provided in red wine by far exceed the biological effects of plain resveratrol.
16/03/2009
MERCK KGaA has released follow-up safety data from a randomized Phase IIb study of patients with inoperable advanced (stage IIIb/IV) non-small cell lung cancer (NSCLC).
10/06/2009
NEUREN Pharmaceuticals says it has obtained US$14m ($17.58m) of additional funding from the US Army, funding most of the costs for the upcoming NNZ-2566 Phase 2 trial.
03/07/2009